@article{10902/20280,
year = {2020},
month = {10},
url = {http://hdl.handle.net/10902/20280},
abstract = {The immunosuppressive treatment that recipients receive from a solid organ transplantation hinders the defensive response to infection. Its transmission from the donor can cause dysfunction or loss of the graft and even death of the recipient if proper preventive measures are not established. This potential risk should be thoroughly evaluated to minimise the risk of infection transmission from donor to recipient, especially with organ transplantation from donors with infections, without increasing graft dysfunction and morbidity and mortality in the recipient. This document aims to review current knowledge about infection screening in potential donors and offer clinical and microbiological recommendations about the use of organs from donors with infection based on available scientific evidence.},
organization = {This work was supported by GESITRA/SEIMC, ONT and‘Plan Nacional de I+D+I’ and Instituto de Salud Carlos III(Fondo de Investigaciones Sanitarias 12/02269 and ProyectoIntegrado de Excelencia 13/00045), Subdirección General de Redesy Centros de Investigacion Cooperativa, Spanish Ministry of Econ-omy and Competitiveness, Spanish Network for Research inInfectious Diseases (REIPI RD16/0016), co-financed by the Euro-pean Development Regional Fund A way to achieve Europe.},
publisher = {Elsevier},
publisher = {Enferm Infecc Microbiol Clin
. 2020 Oct;38(8):379-389},
title = {Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases},
author = {Len, Óscar and Los-Arcos, Ibai and Aguado García, José María and Blanes, Marino and Bodro, Marta and Carratalá Fernández, Jordi and Cordero, Elisa and Fariñas Álvarez, María del Carmen and Fernández Ruiz, Mario and Transplant Infection Study Group GESITRA},
}